Clinical Trial Update: Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a beta-tricalcium phosphate bone graft for patients undergoing surgery for metastatic spine cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Bone Metastases
• Spinal Cord Compression
• Spinal Cord Neoplasm

Drugs mentioned

• Beta-Tricalcium Phosphate Bone Graft (beta-tricalcium phosphate bone graft)

Snippet

Sponsor: University of Southern California | Conditions: Adult Spinal Cord Neoplasm, Spinal Bone Metastases | Phase 1 | Status: TERMINATED